Global Sleeping Aids Market by Manufacturers, Regions, Type and Application, Forecast to 2031

 Sleeping Aids Market 2022

The global Sleeping Aids Market is expected to go great guns in the next 10 years. It is slated to reach US$ 40.1 Bn by the year 2031. The CAGR would be 4.5%. With mixed reality in the foray, virtual objects could be integrated with the real-life ambience, thereby rendering simultaneous manipulation of digital twins. In other words, digital twinning is expected to be the future of healthcare vertical in the forecast period.

As per Persistence Market Research’s latest revised industry analysis, the global Sleeping aids market was valued at over 24.6 Bn in 2020, and is expected to exhibit a CAGR of close to 4.5% over the forecast period (2021-2031).

Increasing prevalence of Sleeping-related disorders, changing lifestyles, obesity, and increasing aging population, together with technology advancements with the launch of innovative devices are some of the factors driving demand for Sleeping aids.

Get Free Sample Of Sleeping Aids Market Report@ https://www.persistencemarketresearch.com/samples/2832

Increasing demand for Sleepinging pills due to modern lifestyles is one of the major factor driving demand for Sleeping aids. Stressful pace of life is found to be the main characteristic of modern lifestyle, thus increasing the incidence of Sleeping-related disorders. According to the Centers for Disease Control and Prevention (CDC) 2020 report, one-third of the U.S. population gets less than the recommended amount of Sleeping on a regular basis.

Company Profiles:

• ResMed Inc.
• Royal Philips NV
• Merck & Co. Inc.
• Drive DeVilbiss Healthcare LLC
• GlaxoSmithKline Plc.
• Fisher & Paykel Healthcare Limited
• Sanofi SA
• Pfizer Inc

Look Through The “Methodology” Employed@ https://www.persistencemarketresearch.com/methodology/2832

Key Takeaways from Market Study

• By product, mattresses and pillows, chin straps, mouth pieces, and nasal devices will hold a market share of 72.5% in 2021, expanding at a CAGR of around 4.3% over the forecast period.
• By indication, insomnia is expected to hold well over 35% market share in 2021, and is expected to continue growing at a moderate rate over the forecast period.
• By distribution channel, the e-Commerce and others segments together holds more than 50% market share, and are expected to continue a similar trend through the forecast period.
• By region, North America held the highest share in the global market in 2020, with the market expanding at a CAGR of nearly 4%.

“Growing incidence of Sleepinging disorders and rising need for technologically advanced products for their treatment are expected to drive market growth over the forecast period,” says an analyst of Persistence Market Research.

Market Competition

New product launches and acquisitions have emerged as a key growth strategy adopted by some of the leading manufacturers of Sleeping aids. By focusing on these strategies, key stakeholders are expanding their geographic footprints and strengthening their existing product portfolios.

• 04-Feb-2020, Merck & Co/MSD claimed FDA approval for a new use of its insomnia drug Belsomra, treating Sleeping disruption in people with mild-to-moderate Alzheimer’s disease.
• In January 2019, GSK announced that it completed the acquisition of Tesaro for approximately US$ 5.1 Bn.
• In 2018, Philips acquired NightBalance, a digital health company in the Netherlands, which has developed an innovative, easy-to-use device to treat positional obstructive Sleeping apnea and positional snoring.
• In August 2017, Sanofi S.A. announced the acquisition of Protein Sciences, a vaccines biotechnology company based in Meriden, Connecticut, in the United States.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the Sleeping aids market in its latest study, presenting historical demand assessment of 2016 – 2020 and projections for 2021 – 2031.

The research study is based on product (drugs {insomnia treatment drugs [doxepin hydrochloride, eszopiclone, ramelteon, triazolam, zaleplon, quazepam, and others], narcolepsy treatment drugs [modafinil, sodium oxybate, armodafinil, and others]}, devices {CPAP devices, BIPAP devices, and APAP devices}, others {mattresses & pillows, chin straps, nasal devices and mouthpieces}), by indication (insomnia, Sleeping deprivation, narcolepsy, Sleeping apnea, and others), and distribution channel (hospital pharmacies, retail pharmacies, e-Commerce, drug stores, and others), across five key regions of the world.

Purchase Our Sleeping Aids Market Report Now@ https://www.persistencemarketresearch.com/checkout/2832

Sleeping Aids Market – Report Highlights

• A detailed overview of parent market of Sleeping Aids Market
• Changing Sleeping Aids Market dynamics in the industry
• In-depth segmentation of the Sleeping Aids Market
• Historical, current, and projected Sleeping Aids Market size regarding volume and value
• Recent industry trends and developments in Sleeping Aids Market
• Competitive landscape of the Sleeping Aids Market
• Strategies for key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on Sleeping Aids Market performance
• Must-have information for Sleeping Aids Market players to sustain and enhance their market footprint

If you have any special requirements, please let us know and we will offer you the report as you want and also We Provide you Table of Content.

About Us: – 

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com